REPLAGAL
Live / Registered — Registered and renewed (as of 07 Sept 2017)
What this means for you
Registered since 07 Aug 2007. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 07 Aug 2017).
Record
- Serial number
- 77021430
- Registration number
- 3273816
- Mark type
- Stylized text
- Filed
- 15 Oct 2006
- Published for opposition
- 22 May 2007
- Registered
- 07 Aug 2007
- Next maintenance due
- 07 Aug 2017
- Attorney of record
- Karl M. Zielaznicki, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of enzyme deficiencies; Pharmaceutical preparations for the treatment of Fabry disease
Owner
- Shire Human Genetic Therapies, Inc., Lexington, MA, US
- Shire Human Genetic Therapies, Inc., Cambridge, MA, US
- Shire Human Genetic Therapies, Inc., Cambridge, MA, US
Prior registrations
Prosecution history
- 01 Jul 2020 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 01 Jul 2020 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 01 Jul 2020 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 01 Jul 2020 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 01 Jul 2020 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 07 Sept 2017 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 07 Sept 2017 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 07 Sept 2017 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 06 Sept 2017 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 26 Jul 2017 — TEAS SECTION 8 & 9 RECEIVED
- 26 Jul 2017 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 07 Aug 2016 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 20 Aug 2013 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 20 Aug 2013 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 02 Aug 2013 — REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED